PAR paradigm biopharmaceuticals limited..

Ann: PAR Appoints Business Development Consultant, page-169

  1. 1,771 Posts.
    lightbulb Created with Sketch. 208
    If 800M shares gets us through the whole process
    to market Zilosul, instead of maybe what we
    were expecting (300-400M), it means our
    shares will be worth half of what we expected.
    Surely that is better then a deal where PAR is
    jammed into a grubby little agreement with a
    partner for say 10% of sales.

    I really don’t see why you think such a dilution
    would be the death of the company. I am not trying
    to be a smart arse. Genuinely would like to know.

    Most of us are way down on our initial purchases.
    From a personal point of view, I would not like to see
    such a dilution, as I am in no position to participate
    in such a CR. (I guess if instos stumped up at 43c,
    then they are likely to participate @ 20-25c),
    However, I think it is the lesser of the other evils
    we face. If we have not been able to make a deal
    during the past couple of years, then there is fat
    chance of a good deal now with the precarious
    financial position we face.




 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
28.0¢
Change
0.000(0.00%)
Mkt cap ! $115.3M
Open High Low Value Volume
28.5¢ 29.0¢ 27.5¢ $266.0K 933.1K

Buyers (Bids)

No. Vol. Price($)
2 30648 28.0¢
 

Sellers (Offers)

Price($) Vol. No.
29.0¢ 20000 1
View Market Depth
Last trade - 16.10pm 18/09/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.